학술논문

FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Document Type
Article
Source
In Annals of Oncology August 2019 30(8):1289-1297
Subject
Language
ISSN
0923-7534